Covered recipient · General Payments record
DOMINIQUE NICOLE BLAGOJEVIC
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2023–2024
$549.63
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $281.87 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $91.02 | 5 |
| Lilly USA, LLC | $81.81 | 5 |
| Acerta Pharma LLC | $34.84 | 2 |
| Phathom Pharmaceuticals, Inc. | $21.06 | 1 |
| ResMed Corp | $20.04 | 1 |
| GlaxoSmithKline, LLC. | $17.47 | 1 |
| Novo Nordisk AS | $15.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.18 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769474 | CMS |
| ABBVIE INC. | $18.66 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769479 | CMS |
| ABBVIE INC. | $13.67 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769483 | CMS |
| ABBVIE INC. | $20.36 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769486 | CMS |
| ABBVIE INC. | $19.15 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106769489 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.47 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105804562 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.37 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104569266 | CMS |
| GlaxoSmithKline, LLC. | $17.47 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116082578 | CMS |
| Lilly USA, LLC | $14.32 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135611425 | CMS |
| Lilly USA, LLC | $20.45 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135549455 | CMS |
| Lilly USA, LLC | $16.34 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135634864 | CMS |
| Lilly USA, LLC | $15.08 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135549457 | CMS |
| Lilly USA, LLC | $15.62 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135634862 | CMS |
| Novo Nordisk Inc | $15.63 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100291332 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.06 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151149351 | CMS |
| Resmed Corp | $20.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140205145 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.